Haslam College of Business at the University of Tennessee
Master of Business Administration (MBA) (Physician Executive MBA)
2014 - 2015
Harvard Business School
General Management Program
2014 - 2014
Memorial Sloan Kettering Cancer Center
Surgical Oncology Fellowship
1999 - 2001
Walter Reed Army Medical Center
General Surgery Residency Program
1991 - 1997
Uniformed Services University of the Health Sciences
MD (Medicine)
1987 - 1991
United States Military Academy at West Point
BS (Biochemistry)
1983 - 1987
University of Maryland, Baltimore (UMB)
Master of Science in Regulatory Science (Drug and Biologics Discovery, Research, Development and Regulation)
2020
Alexander Stojadinovic's Skills
Clinical Research
Healthcare
Medicine
Healthcare Management
Hospitals
Clinical Trials
Cancer
Leadership
Surgery
Program Management
Alexander Stojadinovic's Summary
Alexander Stojadinovic, based in Collegeville, Pennsylvania, United States, is currently a Senior Medical Director - Oncology Clinical Development - Synthetic Lethality at GSK, bringing experience from previous roles at Amerigroup, P8 Medicine LLC and Bon Secours Health System. Alexander Stojadinovic holds a 2014 - 2015 Master of Business Administration (MBA) in Physician Executive MBA @ Haslam College of Business at the University of Tennessee. With a robust skill set that includes Clinical Research, Healthcare, Medicine, Healthcare Management, Hospitals and more, Alexander Stojadinovic contributes valuable insights to the industry. Alexander Stojadinovic has 3 emails and 1 mobile phone number on RocketReach.